logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8906853 B1

PDFFull Text
Date of Patent:
Dec. 09, 2014

Filed:

Nov. 27, 2013

[n-me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis c infection

Applicant:

Enanta Pharmaceuticals, Inc., Watertown, MA (US);

Inventors:

Yat Sun Or, Watertown, MA (US);

In Jong Kim, Lexington, MA (US);

Jiang Long, Wayland, MA (US);

Lijuan Jiang, Newton, MA (US);

Sheng Sean Liu, Shrewsbury, MA (US);

Guoqiang Wang, Belmont, MA (US);

Assignee:

Enanta Pharmaceuticals, Inc., Watertown, MA (US);

Attorneys:

Edgar W. Harlan

Carolyn S. Elmore, Esq.

Elmore Patent Law Group, P.C.

Primary Examiner:

Karlheinz R Skowronek

Assistant Examiner:

Mindy Newman

Int. Cl.
CPC ...
A61K 38/21 (2006.01); A61K 31/7056 (2006.01); A61K 45/06 (2006.01); C07K 7/64 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
C07K 7/645 (2013.01); A61K 31/7056 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61K 31/713 (2013.01);
Abstract

The present invention relates to novel cyclosporine analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.

Find Patent Forward Citations

Quick Actions:

Or, Yat. (2014). [n-me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis c infection (U.S. Patent No. 8906853). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8906853

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…